Ready to cut time to save lives? Request consultation
Future-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
“A huge advantage”
Listen to Ehsan Ghaderi, Head of Department, and Sofia Persson, Consultant Physician, Bacteriology Uppsala University Hospital, talks about how ASTar have helped save time in the lab.
“You will be much faster in adjusting the treatment”
Listen to Martin Sundqvist, Senior consultant, PhD, Clinical Microbiology, Örebro University Hospital. President of the Swedish Society of Clinical Microbiology speak about the value of rapid AST, true MIC values and more.
Find more words about us here
News & events
The proposal by the nomination committee of Q-linea AB (publ) for election of members of the board of directors
Q-linea AB appoints ABG Sundal Collier as liquidity provider
Q-linea is granted a short-term interest-free loan from the main owner Nexttobe within the framework of the previously communicated loan facility
Q-linea AB (publ) (OMX: QLINEA) – Q-linea announces today that the company’s main owner Nexttobe has granted Q-linea a…
Read more >
Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.